NCT02034019View on ClinicalTrials.gov

Phase 3 Study Evaluating Safety and Efficacy of OTX-DP for Treatment of Ocular Inflammation and Pain After Cataract Surgery

PHASE3CompletedINTERVENTIONAL
Enrollment

247

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

December 31, 2014

Study Completion Date

February 28, 2015

Conditions
Post Ocular Surgical Inflammation and Pain
Interventions
DRUG

Dexamethasone

DRUG

Punctum Plug

Trial Locations (1)

78731

Texan Eye / Keystone Research, Ltd., Austin

Sponsors
All Listed Sponsors
lead

Ocular Therapeutix, Inc.

INDUSTRY